Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQ2BU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,278
Award facts
- Contract value 100% obligated
- $17,277.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,277.71 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. This delivery order for Cosentyx, a specialty immunology medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements across the federal healthcare supply chain through competitive, firm fixed-price transactions.
Quick answers
Who was awarded contract SPE2DB25FQ2BU?
SPE2DB25FQ2BU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FQ2BU worth?
The government has obligated $17,278 on SPE2DB25FQ2BU.
Is contract SPE2DB25FQ2BU an order under another contract?
Yes. SPE2DB25FQ2BU is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2BU competed?
The extent of competition for SPE2DB25FQ2BU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award